Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01065714 · ClinicalTrials.gov registry record · Phase 4

A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis

A Phase 4 study, sponsored by Derm Research, PLLC.

Completed
Registry status
Phase 4
Development phase
20
Enrollment target

NCT01065714: Completed Phase 4 study, sponsored by Derm Research, PLLC.

NCT01065714 is a Phase 4 study that has completed, run by Derm Research, PLLC. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01065714, a Phase 4 study, has completed, sponsored by Derm Research, PLLC.

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target

Study Summary

While the repair of the epidermal barrier in atopic dermatitis is of major importance in the treatment of atopic dermatitis, most of the vehicles used may actually cause a worsening of an impaired epidermal barrier. Hydrogel vehicle is anecdotally known to be moisturizing and hydrating.This study will compare the use of Hydrogel vehicle and Eucerin Lotion in maintaining the epidermal barrier in subjects with atopic dermatitis.

Primary Outcome

The average of three sequential Tewameter 300 meter readings taken at a minimum of one minute intervals on targeted area of body half treated with Eucerin lotion

Interventions

  • DRUG Hydrogel vehicle
  • DRUG Eucerin Lotion

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-02
Est. Completion 2010-11
Phase Phase 4
Derm Research, PLLC

11 total trials

What the finished NCT01065714 record still lists

NCT01065714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Hydrogel vehicle is the first listed.

NCT01065714 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01065714 about?

NCT01065714 is a clinical study titled "A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis". While the repair of the epidermal barrier in atopic dermatitis is of major importance in the treatment of atopic dermatitis, most of the vehicles used may actually cause a worsening of an impaired epidermal barrier. Hydrogel vehicle is anecdotally known to be moisturizing and hydrating.This study wi...

What is the current status of trial NCT01065714?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2010-02. Estimated completion is 2010-11.

What interventions are being tested in trial NCT01065714?

The interventions under investigation include: Hydrogel vehicle (DRUG), Eucerin Lotion (DRUG).

Who is sponsoring clinical trial NCT01065714?

This trial is sponsored by Derm Research, PLLC, which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01065714's enrollment target sits among peer trials

20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01065714, the US trial registry maintained by the National Library of Medicine. NCT01065714 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.